首页> 外文期刊>Bone marrow transplantation >The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model.
【24h】

The effect of administration order of BU and CY on engraftment and toxicity in HSCT mouse model.

机译:BU和CY的给药顺序对HSCT小鼠模型的植入和毒性的影响。

获取原文
获取原文并翻译 | 示例
       

摘要

Conditioning regimens are an important issue determining the outcome of hematopoietic stem cell transplantation (HSCT). Less toxicity, early engraftment and no relapse are the aims of efficient conditioning. Our objective was to investigate the long-term effects of BU-CY and their administration order on the toxicity and chimerism in a mouse model of HSCT. Female BALB/c mice were treated with either BU (15 mg/kg/day x 4)-CY (100 mg/kg/day x 2) or CY-BU. Treated mice were transplanted with Sca-1+ cells from male BALB/c mice. Until 90 days after HSCT, the animals were monitored for body weight and analyzed for cellular phenotype of the thymus, spleen and BM, total chimerism, the spleen chimerism of DCs and T regulatory (Treg) cells, and hepatotoxicity. BU-CY and CY-BU treatments exerted comparable myeloablative and immunosuppressive effects. The long-term engraftment of donor cells in the BM and thymus regeneration showed the same features in both groups. However, the two regimens differed; in general, hepatotoxicity and chimerism of DC and Treg cells. In the long term, BU-CY, but not CY-BU caused a marked decrease in body weight and a significant increase in the activities of the liver enzymes, particularly aspartate amino transferase (AST). We conclude that the alteration of the administration order of BU-CY to CY-BU not only gives the same level of engraftment but also reduces the toxicity of the conditioning regimen that might be valuable specially in young patients who are undergoing HSCT.
机译:调理方案是决定造血干细胞移植(HSCT)结果的重要问题。毒性小,早期植入和无复发是有效调理的目的。我们的目的是研究BU-CY的长期作用及其给药顺序对HSCT小鼠模型的毒性和嵌合作用。用BU(15 mg / kg /天x 4)-CY(100 mg / kg /天x 2)或CY-BU治疗雌性BALB / c小鼠。用来自雄性BALB / c小鼠的Sca-1 +细胞移植经治疗的小鼠。直到HSCT后90天,监测动物的体重并分析其胸腺,脾脏和BM的细胞表型,总嵌合体,DC和T调节(Treg)细胞的脾脏嵌合体以及肝毒性。 BU-CY和CY-BU治疗具有相当的清髓和免疫抑制作用。供体细胞在BM和胸腺再生中的长期植入在两组中显示出相同的特征。但是,两种方案不同。通常,DC和Treg细胞具有肝毒性和嵌合作用。从长远来看,BU-CY而不是CY-BU引起体重的显着降低和肝脏酶(尤其是天冬氨酸氨基转移酶)的活性的显着增加。我们得出结论,从BU-CY到CY-BU的给药顺序的改变不仅使移植水平相同,而且还降低了调理方案的毒性,这在正在接受HSCT的年轻患者中可能特别有价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号